BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1433 related articles for article (PubMed ID: 31678422)

  • 21. FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis.
    Ji T; Zhang Y; Wang Z; Hou Z; Gao X; Zhang X
    Cancer Biomark; 2020; 29(3):417-427. PubMed ID: 32924985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. lncRNA FOXD3-AS1 promotes the progression of non-small cell lung cancer by regulating the miR-135a-5p/CDK6 axis.
    Guo H; Lin S; Gan Z; Xie J; Zhou J; Hu M
    Oncol Lett; 2021 Dec; 22(6):853. PubMed ID: 34733371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p/MYCBP axis.
    Li C; Tan F; Pei Q; Zhou Z; Zhou Y; Zhang L; Wang D; Pei H
    Cell Prolif; 2019 Jul; 52(4):e12632. PubMed ID: 31094023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA DCST1-AS1/hsa-miR-582-5p/HMGB1 axis regulates colorectal cancer progression.
    Huang L; Dai G
    Bioengineered; 2022 Jan; 13(1):12-26. PubMed ID: 34967274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LncRNA MCM3AP-AS1 promotes proliferation and invasion through regulating miR-211-5p/SPARC axis in papillary thyroid cancer.
    Liang M; Jia J; Chen L; Wei B; Guan Q; Ding Z; Yu J; Pang R; He G
    Endocrine; 2019 Aug; 65(2):318-326. PubMed ID: 31030335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway.
    Cheng B; Rong A; Zhou Q; Li W
    J Exp Clin Cancer Res; 2020 Jan; 39(1):5. PubMed ID: 31900207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA AFAP-AS1 promotes anaplastic thyroid cancer progression by sponging miR-155-5p through ETS1/ERK pathway.
    Ning M; Qin S; Tian J; Wang Y; Liu Q
    Bioengineered; 2021 Dec; 12(1):1543-1554. PubMed ID: 33999777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. OTUD6B-AS1 Inhibits Viability, Migration, and Invasion of Thyroid Carcinoma by Targeting miR-183-5p and miR-21.
    Wang Z; Xia F; Feng T; Jiang B; Wang W; Li X
    Front Endocrinol (Lausanne); 2020; 11():136. PubMed ID: 32256450
    [No Abstract]   [Full Text] [Related]  

  • 32. FoxD2-AS1 promotes glioma progression by regulating miR-185-5P/HMGA2 axis and PI3K/AKT signaling pathway.
    Ni W; Xia Y; Bi Y; Wen F; Hu D; Luo L
    Aging (Albany NY); 2019 Mar; 11(5):1427-1439. PubMed ID: 30860979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
    Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis.
    Zhang X; Zhang X; Jia Q; Li H; Ma R; Yang G; Yin F; Jiang N; Yin D
    BMC Cancer; 2022 Mar; 22(1):344. PubMed ID: 35351042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y; Lv M; Fang Y; Lu J; Wu Y
    J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NEAT1 induces osteosarcoma development by modulating the miR-339-5p/TGF-β1 pathway.
    Zhang L; Lu XQ; Zhou XQ; Liu QB; Chen L; Cai F
    J Cell Physiol; 2019 Apr; 234(4):5097-5105. PubMed ID: 30203547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
    Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
    Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA AFAP1-AS1 regulates proliferation and apoptosis of endometriosis through activating STAT3/TGF-β/Smad signaling via miR-424-5p.
    Huan Q; Cheng SC; Du ZH; Ma HF; Li C
    J Obstet Gynaecol Res; 2021 Jul; 47(7):2394-2405. PubMed ID: 33949053
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Wan N; Yang W; Cheng H; Wang J
    Cancer Biother Radiopharm; 2020 Oct; 35(8):596-604. PubMed ID: 32354225
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 72.